Bundamedik Tbk PT (BMHS) — Cash Flow Reinvestment Rate
Bundamedik Tbk PT (BMHS) has a Cash Flow Reinvestment Rate of 0.58x as of December 2025, reinvesting Rp116.26 Billion (capex Rp116.26 Billion ) from operating cash flow of Rp199.64 Billion. Check BMHS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bundamedik Tbk PT Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Bundamedik Tbk PT across 8 annual periods. Explore BMHS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Bundamedik Tbk PT (2018–2025)
Year-by-year capital reinvestment analysis for Bundamedik Tbk PT. For live market cap and broader valuation context, see BMHS market cap overview.
| Year | Reinvestment Rate | Total Reinvested (IDR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.87x | Rp218.91 Billion | Rp250.62 Billion | Rp218.91 Billion | ▼ -93.8% |
| 2024 | 14.16x | Rp481.32 Billion | Rp33.98 Billion | Rp236.03 Billion | ▲ +72.8% |
| 2023 | 8.20x | Rp421.57 Billion | Rp51.44 Billion | Rp209.35 Billion | ▲ +163.1% |
| 2022 | 3.12x | Rp739.76 Billion | Rp237.47 Billion | Rp301.73 Billion | ▲ +336.2% |
| 2021 | 0.71x | Rp249.57 Billion | Rp349.44 Billion | Rp228.08 Billion | ▲ +91.2% |
| 2020 | 0.37x | Rp71.10 Billion | Rp190.36 Billion | Rp49.61 Billion | ▼ -60.2% |
| 2019 | 0.94x | Rp84.26 Billion | Rp89.72 Billion | Rp72.50 Billion | ▼ -73.7% |
| 2018 | 3.57x | Rp156.54 Billion | Rp43.79 Billion | Rp156.54 Billion | — |